Page 30 - Dr Stephanie Seneff - Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID - 19

genome (Wang et al., 2004). In fact, such a process has been suggested as a basis for Lamarckian
evolution defined as the inheritance of acquired traits (Steele, 1980).

The realization that what was formerly called “junk DNA” is not junk, is just one of the results
coming out of the new philosophical paradigm in human language, biology and genetics that is based
on fractal genomics (Pellionisz, 2012) — a paradigm that Pellionisz has linked to the involvement of
"true narrative representations" (TNRs; Oller, 2010), realized as “iterations of a fractal template” in
the highly repetitive processes of normal development of the many branching structures of the
human body. These processes are numerous in the lungs, kidneys, veins and arteries, and most
importantly in the brain. The mRNA vaccines are an experimental gene therapy with the potential
to incorporate the code for the SARS-CoV-2 spike protein into human DNA. This DNA code
could instruct the synthesis of large numbers of copies of proteinaceous infectious particles, and this
has the potential to insert multiple false signals into the unfolding narrative, resulting in
unpredictable outcomes.

Conclusion

Experimental mRNA vaccines have been heralded as having the potential for great benefits, but they
also harbor the possibility of potentially tragic and even catastrophic unforeseen consequences. The
mRNA vaccines against SARS-CoV-2 have been implemented with great fanfare, but there are many
aspects of their widespread utilization that merit concern. We have reviewed some, but not all, of
those concerns here, and we want to emphasize that these concerns are potentially serious and might
not be evident for years or even transgenerationally. In order to adequately rule out the adverse
potentialities described in this paper, we recommend, at a minimum, that the following research and
surveillance practices be adopted:

• A national effort to collect detailed data on adverse events associated with the mRNA
vaccines with abundant funding allocation, tracked well beyond the first couple of weeks
after vaccination.
• Repeated autoantibody testing of the vaccine-recipient population. The autoantibodies tested
could be standardized and should be based upon previously documented antibodies and
autoantibodies potentially elicited by the spike protein. These include autoantibodies against
phospholipids, collagen, actin, thyroperoxidase (TPO), myelin basic protein, tissue
transglutaminase, and perhaps others.

• Immunological profiling related to cytokine balance and related biological effects. Tests
should include, at a minimum, IL-6, INF-α, D-dimer, fibrinogen, and C-reactive protein.
• Studies comparing populations who were vaccinated with the mRNA vaccines and those
who were not to confirm the expected decreased infection rate and milder symptoms of the
vaccinated group, while at the same time comparing the rates of various autoimmune
diseases and prion diseases in the same two populations.
• Studies to assess whether it is possible for an unvaccinated person to acquire vaccine-specific
forms of the spike proteins from a vaccinated person in close proximity.
• In vitro studies to assess whether the mRNA nanoparticles can be taken up by sperm and
converted into cDNA plasmids.

International Journal of Vaccine Theory, Practice, and Research 2(1), May 10, 2021 Page | 418